Načítá se...
Hepatic inflammation and progressive liver fibrosis in chronic liver disease
Chronic liver inflammation drives hepatic fibrosis, and current immunosuppressive, anti-inflammatory, and anti-viral therapies can weaken this driver. Hepatic fibrosis is reversed, stabilized, or prevented in 57%-79% of patients by conventional treatment regimens, mainly by their anti-inflammatory a...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Baishideng Publishing Group Co., Limited
2014
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3949261/ https://ncbi.nlm.nih.gov/pubmed/24627588 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i10.2515 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|